Cargando…
CBFA2T3-GLIS2 model of pediatric acute megakaryoblastic leukemia identifies FOLR1 as a CAR T cell target
The CBFA2T3-GLIS2 (C/G) fusion is a product of a cryptic translocation primarily seen in infants and early childhood and is associated with dismal outcome. Here, we demonstrate that the expression of the C/G oncogenic fusion protein promotes the transformation of human cord blood hematopoietic stem...
Autores principales: | Le, Quy, Hadland, Brandon, Smith, Jenny L., Leonti, Amanda, Huang, Benjamin J., Ries, Rhonda, Hylkema, Tiffany A., Castro, Sommer, Tang, Thao T., McKay, Cyd N., Perkins, LaKeisha, Pardo, Laura, Sarthy, Jay, Beckman, Amy K., Williams, Robin, Idemmili, Rhonda, Furlan, Scott, Ishida, Takashi, Call, Lindsey, Srivastava, Shivani, Loeb, Anisha M., Milano, Filippo, Imren, Suzan, Morris, Shelli M., Pakiam, Fiona, Olson, Jim M., Loken, Michael R., Brodersen, Lisa, Riddell, Stanley R., Tarlock, Katherine, Bernstein, Irwin D., Loeb, Keith R., Meshinchi, Soheil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663156/ https://www.ncbi.nlm.nih.gov/pubmed/36136600 http://dx.doi.org/10.1172/JCI157101 |
Ejemplares similares
-
Targeting FOLR1 in high-risk CBF2AT3-GLIS2 pediatric AML with STRO-002 FOLR1–antibody-drug conjugate
por: Tang, Thao, et al.
Publicado: (2022) -
Acute megakaryoblastic leukemia with trisomy 3 and
CBFA2T3::GLIS2
: A case report
por: Gillam, Joseph, et al.
Publicado: (2022) -
Preclinical studies targeting CD74 with STRO-001 antibody-drug conjugate in acute leukemia
por: Le, Quy, et al.
Publicado: (2023) -
Therapeutic Targeting of Mesothelin with Chimeric Antigen Receptor T Cells in Acute Myeloid Leukemia
por: Le, Quy, et al.
Publicado: (2021) -
Clinical Courses of Two Pediatric Patients with Acute Megakaryoblastic Leukemia Harboring the CBFA2T3-GLIS2 Fusion Gene
por: Ishibashi, Mayu, et al.
Publicado: (2016)